Curriculum Vitae

PROF. DR. JESJEET SINGH GILL A/L JESWANT SINGH

Professor
  • Department of Psychological Medicine
    Faculty of Medicine
  • 79502068

AREAS OF EXPERTISE

  • PSYCHIATRY
    Urban Mental Health
  • PSYCHIATRY
    Early Psychosis
  • PSYCHIATRY
    Psychosexuality

ACADEMIC QUALIFICATION

  • MMED(UM), (Psikologi)
    Universiti Malaya (UM)
  • MBBS(UM), (Medicine and Surgery)
    Universiti Malaya (UM)

ADMINISTRATIVE DUTIES

  • Pengurus Psikofarmakologi
    01 Apr 2008 - present (Faculty)
  • Examiner for Final MBBS examinations
    10 Mar 2008 - present (Faculty)
  • Submitting and vetting Masters in Psychological Medicine Part 1 and 2 Exams questions (Conjoint UM-UKM-USM)
    31 Mar 2008 - present (University Malaya)
  • Submitting questions and vetting committee for OSCE and Problem solving for Final MBBS Exams
    01 Feb 2008 - present (Faculty)
  • Head and Coordinator of Early Intervention in Psychosis Programm
    01 Jun 2004 - present (Faculty)
  • Ahli Jawatankuasa Ijazah Tingggi Fakulti Perubatan (JKITFP)
    01 Jul 2011 - present (Faculty)
  • Secretary- Psychiatry Interuniversity Conjoint Board (Jawatankuasa Bersama Sarjana Perubatan: Psikiatri)
    01 Jul 2009 - present (National)
  • Departmental Medical Reports - Moderator
    01 Jun 2010 - present (Faculty)
  • Acting Head of Department
    12 Jun 2015 - present (University Malaya)
  • Anti - bully committee
    01 Jul 2018 - 30 Jun 2019 (Faculty)
  • Acting Head of Department
    01 Jan 2018 - 31 Jul 2018 (Faculty)
  • Acting Head of Department
    21 Sep 2015 - 24 Sep 2015 (Faculty)
  • Acting Head of Department
    06 Jul 2015 - 12 Jul 2015 (University Malaya)
  • Acting Head of Department
    31 Mar 2015 - 05 Apr 2015 (Faculty)
  • Acting Head of Department
    26 Nov 2014 - 31 Dec 2014 (Faculty)
  • Acting Head of Department
    21 Oct 2014 - 24 Oct 2014 (Faculty)
  • Acting Head of Department
    04 Jun 2012 - 08 Jun 2012 (Faculty)
  • Committee Member of Technical Evaluation of Audiovisual Aids for Teaching, Exams and Research in Dept of Psychological Medicine
    01 Jan 2005 - 31 Dec 2006 (Faculty)

MEMBERSHIPS

  • MALAYSIAN PSYCHIATRIC ASSOCIATION, MEMBER
    2003 to present (National)
  • WORLD PSYCHIACTRIC ASSOCIATION - SECTION ON URBAN MENTAL HEALTH, COMMITTEE MEMBER
    2018 to present (International)
  • AJK VAKSIN FASA 2, MEMBER
    2021 to 2022 (National)
  • WORLD PSYCHIATRIC ASSOCIATION SECTION ON URBAN MENTAL HEALTH, MEMBER
    2018 to 2022 (International)
  • PROJEK KURRIKULUM NASIONAL SARJANA PERUBATAN KLINIKAL, COMMITTEE MEMBER
    2016 to 2022 (National)
  • JAWATANKUASA BERSAMA KEPAKARAN PSIKIATRI MALAYSIA, COMMITTEE MEMBER
    2015 to 2022 (National)
  • PROJEK KURIKULLUM NASIONAL SRJANA PERUBATAN KLINIKAL, COMMITTEE MEMBER
    2016 to 2022 (National)
  • CARIPRAZINE ADVISORY BOARD, ADVISORY BOARD
    2021 to 2021 (National)
  • AHLI JAWANTANKUASA PENGGUBAL POLISI ANTI BULI FAKULTI PERUBATAN, COMMITTEE MEMBER
    2018 to 2021 (University)
  • WORLD PSYCHIATRIC ASSOCIATION SECTION ON URBAN MENTAL HEALTH , COMMITTEE MEMBERS
    2015 to 2020 (International)
  • WORLD PSYCHIATRIC ASSOCIATION - SECTION ON URBAN MENTAL HEALTH, BOARD MEMBER
    2015 to 2020 (International)

AWARD AND STEWARDSHIP

  • Certificate of Achievement Recruiting and Randomizing Firts Patient in Asia Pacific for Aspire I Study
    Johnson and Johnson, 2017 (International)
  • SIJIL PENGHARGAAN PENCERAMAH BENGKEL PEMANTAPAN CALON POST GRADUASI 2017, PUSAT PERUBATAN UNIVERSITI MALAYA
    kementerian Kesihatan Malaysia, 2017 (University)
  • CERTIFICATE OF APPRECIATION ORGANIZER, POST GRADUATE PSYCHIATRY RESEARCH COMPETITION, DEPT OF PSYCHOLOGICAL MEDICINE, UNIVERSITY MALAYA
    MALAYSIAN PSYCHIATRIC ASSOCIATION, 2015 (University)
  • Top Recruiter for Clinical Trials
    Dept of Psychological Medicine, 2015 (Department)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2014 (University)
  • Sijil Penghargaan Analisa dan Pembentangan Hasil Kajian Premelinari Bagi Kertas Cadangan Rombakan Kurikulum
    JAWATANKUASA PENGAJIAN BERSAMA SARJANA KEPAKARAN, 2013 (National)
  • Anugerah Perkhidmatan Cemerlang
    Unuversity Malaya, 2013 (University)
  • Asian Researcher Travel Award
    OTSUKA Pharmaceutical Development Cooperation, Japan, 2012 (International)
  • Honorary Fellow Philippine College of Neuropsychopharmacology
    Philippine College of Neuropsychopharmacology, 2009 (International)
  • Young Psychiatrist Travel Award from Japanese Society of Psychiatry and Neurolgoy
    Japanese Society of Psychiatry and Neurology, 2008 (International)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2007 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2006 (University)
  • Anugerah Perkhidmatan Cemerlang
    Universiti Malaya, 2006 (University)
  • Anugerah Perkhidmatan Cemerlang
    University Malaya, 2005 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2005 (University)
  • Anugerah Perkhidmatan Cemerlang
    University Malaya, 2004 (University)

PUBLICATIONS

Article in Journal
WoS
  1. Franklin, Freddy; Rajamanikam, Arutchelvan; Raju, Chandramathi Samudi; Gill, Jesjeet Singh; Francis, Benedict; Sy-Cherng, Luke Woon; Kumar, Suresh (2022). Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients, PARASITES & VECTORS. 15(1), . doi:10.1186/s13071-022-05418-0
  2. Francis, B., Ken, C. S., Han, N. Y., Ariffin, M. A. A., Yusuf, M. H. M., Wen, L. J., . . . Said, M. A. (2021). Religious Coping During the COVID-19 Pandemic: Gender, Occupational and Socio-economic Perspectives Among Malaysian Frontline Healthcare Workers. Alpha Psychiatry, 22(4), 194-199. doi: 10.5152/alphapsychiatry.2021.21185
  3. Nair, P., Gill, J. S., Sulaiman, A. H., Koh, O. H., & Francis, B. (2021). Mental Health Correlates Among Older Persons Residing in Malaysian Nursing Homes During the COVID-19 Pandemic. Asia-Pacific journal of public health, 33(8), 940-944. doi: 10.1177/10105395211032094
  4. Zaini, S., Sulaiman, A. H., Huri, H. Z., Koh, O. H., Gill, J. S., Francis, B., . . . Guan, N. C. (2021). Patient-Centred Communication in the Use of Antidepressants among People with Depression: A Scoping Review. Sains Malaysiana, 50(1), 161-170. doi: 10.17576/jsm-2021-5001-16
  5. Damodaran, I., Hui, K. O., Nordin, A. S. A., Yee, A., Gill, J. S., Francis, B., . . . Sulaiman, A. H. (2020). An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia. Healthcare, 8(4), 13. doi: 10.3390/healthcare8040533
  6. Kaur, K., Sulaiman, A. H., Yoon, C. K., Hashim, A. H., Kaur, M., Hui, K. O., . . . Gill, J. S. (2020). Elucidating Mental Health Disorders among Rohingya Refugees: A Malaysian Perspective. International journal of environmental research and public health, 17(18), 22. doi: 10.3390/ijerph17186730
  7. Francis, B., Gill, J. S., Han, N. Y., Petrus, C. F., Azhar, F. L., Sabki, Z. A., . . . Sulaiman, A. H. (2019). Religious Coping, Religiosity, Depression and Anxiety among Medical Students in a Multi-Religious Setting. International Journal of Environmental Research and Public Health, 16(2), 13. doi:10.3390/ijerph16020259
  8. Gill, J. S., Pillai, S. K., Koh, O. H., Jambunathan, S. (2010). Non-Fatal Paliperidone Overdose: A Case Report, Turk Psikiyatri Dergisi. 21(4), 331-333
Scopus
  1. Juhari J.A., Gill J.S., Francis B. (2022). Coping Strategies and Mental Disorders among the LGBT+ Community in Malaysia, Healthcare (Switzerland). 10(10), . doi:10.3390/healthcare10101885
  2. Francis, B., Ken, C. S., Yit Han, N., Ariffin, M. A. A., Yusuf, M. H. M., Wen, L. J., . . . Said, M. A. (2021). Religious coping during the covid-19 pandemic: Gender, occupational and socio-economic perspectives among malaysian frontline healthcare workers. Anadolu Psikiyatri Dergisi, 22(4), 194-199. doi: 10.5152/alphapsychiatry.2021.21185
Others
  1. Kaur, K.; Sulaiman, A.H.; Yoon, C.K.; Hashim, A.H.; Kaur, M.; Hui, K.O.; Sabki, Z.A.; Francis, B.; Singh, S.; Gill, J.S. Elucidating Mental Health Disorders among Rohingya Refugees: A Malaysian Perspective. Int. J. Environ. Res. Public Health 2020, 17, 6730.
  2. Francis, B; Gill, JS; Sulaiman, AH; Petrus, CF; Koh, OH. (2019).The antipsychotic property of neoadjuvant chemotherapy regime 5-flourouracil, epidoxorubicin and cyclophosphomide (FEC) in a patient with treatment resistant schizophrenia: a case study. European Psychiatry, 56 S69-S69
  3. Francis, B.; Wah, K. Y.; Jawan, R. A.; Sulaiman, A. H.; Gill, J. S. Correlates and prevalence of anxiety disorders among women with polycystic ovarian syndrome (PCOS): A Malaysian cross-sectional study. European Psychiatry (2018)Volume: 48: S220-S220.
  4. Francis, B.; Wah, K. Y.; Jawan, R. A.; Sulaiman, A. H.; Gill, J. S. Depressive disorders and sexual functioning among Malaysian women with polycystic ovarian syndrome (PCOS): A cross-sectional study. European Psychiatry (2018)Volume: 48: S219-S219
  5. Gill JS, Sulaiman AH. QTc Prolongation and Ventricular Trigemini with Asenapine: A Case Report. Turk Psikiyatri Derg. 2018 ;29(1):67-68.
  6. Lee AMH, Ng CG, Koh OH, Gill JS et al. Metabolic Syndrome in First Episode Schizophrenia, Based on the National Mental Health Registry of Schizophrenia (NMHR) in a General Hospital in Malaysia: A 10-Year Retrospective Cohort Study. International Journal of Environmental Research and Public Health. 15(5):933 May 2018
  7. Ng SH, Ng CG, Gill JS, Koh OH, et al. Core Symptoms of Major Depressive Disorder among Palliative Care Patients. International Journal of Environmental Research and Public Health. 2018 Aug; 15(8): 1758
  8. Syahrir Zaini, Harvin Anbu Manivanna Bharathy, Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Koh Ong Hui, Hasniza Zaman Huri, Siti Hadijah Shamsudin, Ng Chong Guan. (2018).Development of a Strategic Tool for Shared Decision-Making in the Use of Antidepressants among Patients with Major Depressive Disorder: A Focus Group Study. Int. J. Environ. Res. Public Health 2018, 15(7), 1402
  9. FL Azhar, JS Gill, AH Sulaiman. Social anxiety disorder among applicants to the Paychiatry Master s Degree Program in Malaysia. European Neuropsychopharmacology, 27(S4): S982-983
  10. Francis, B.; Jambunathan, S. T.; Gill, J. S. (2017). Asenapine in the treatment of trichotillomania with comorbid bipolar disorder: A case report. European Psychiatry Volume: 41 Pages: S683
  11. Francis, B.; Jambunathan, S. T.; Gill, J. S.; et al. The blue-eyed man: A case of Waardenburg syndrome type 1 associated with mania and autistic spectrum disorder: European Psychiatry Volume: 41 Pages: S421-S422 Published: APR 2017
  12. Gill, Jesjeet Singh; Jambunathan, Stephen; Wong, Sylvia; et al.Paradoxical pinpoint pupils with asenapine. Asia-Pacific Psychiatry Volume: 7 Issue: 2 Pages: 230 Published: JUN 2015
  13. Ng C, Ng S, J Gill. Measuring the Prevalence of Major Depressive Disorder Among Palliative Patients - Comparing Four Sets of Diagnostic Criteria. European Psychiatry,30 (S1):717
  14. Yee A, Kanagasundram S, Gill JS, Zainal NZ. SEXUAL DYSFUNCTION RELATED TO NON-SSRI SECOND GENERATION ANTIDEPRESSANTS: A META-ANALYSIS
  15. Grewal GS, Gill JS et al. Prevalence and risk factors of female sexual dysfunction among healthcare personnel in malaysia. Compr Psychiatry. 2014 Jan;55 Suppl 1:S17-22
  16. S Mohamed, JS Gill, CT Tan. Quality of life of patients with epilepsy in Malaysia. Asia-Pacific Psychiatry 6 (2014) 105-109
  17. Chong Guan Ng, Lee Khing Tan, Jesjeet Singh Gill, Ong Hui Koh, Stephen Jambunathan, Subash Kumar Pillai & Hatta Sidi.Reliability and validity of the Malay version of Attitudes toward Lesbians and Gay Men (MVATL/MVATG): A study on a group of medical students in Malaysia. Asia Pacific Psychiatry 5 (2013) 118 122
  18. Grewal GS, Gill JS, Sidi, Gurpreet K,Jambunathan ST, Suffee NS. Sexual desire disorder in female healthcare personnel in Malaysia. Asia Pacific Psychiatry 5 (2013) 14 20
  19. Guan NC, Hui KO, Gill JS. Methylphenidate for the treatment of erectile dysfunction induced by long acting injectable paliperidone palmitate: a case report. BCP. 2013; 23(4): 361-4.
  20. Koh Ong Hui, Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Subash Kumar Pillai, Stephen Thevanathan Jambunathan, Rusdi Abdul Rashid. A 3-Week, Open Label Study to Evaluate The Efficacy and Safety of Extended Release Quetiapine Fumarate in The Treatment of Agitation in Patients with Schizophrenia. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2013;23(1):14-23
  21. Ahmad Hatim Sulaiman, Jesjeet Singh Gill Jeswant Singh, Mas Ayu Said, Mohamad Hussain Habil, Nor Zuraida Zainal, Chong Guan Ng. An Open-Label Study of Aripiprazole for Methamphetamine Induced Psychosis" (Manuscript Number: 24-1323670066) - accepted for publication - Bulletin of Clinical Psychopharmacology.
  22. Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Mas Ayu Said, Nor Zuraida Zainal, Mohamad Hussein Habil, Ng Chong Guan. A Randomized, Placebo-Controlled Trial of Aripiprazole For The Treatment Of Methamphetamine Dependence and Associated Psychosis, International Journal of Psychiatry in Clinical Practice, 2012;Early Online:1-8
  23. Gill JS, Tan JT, Lee HG et al. Adherence to Metabolic Monitoring Guidelines in Atypical Antipsychotic Treated Subjects: Do Physicians Comply? African Journal of Pharmacy and Pharmacology Vol. 6(1), pp. 13- 16
  24. Kaka AS, Zainal NZ, Gill JS et al.Prevalence of Postpartum Depression in a Hospital Setting among Malaysian Mothers. Asia-Pacific Psychiatry 2011
  25. Lee H. M., Gill J. S., Pillai S. K. and Ng C. G Rapid improvement in medically ill elderly patients treated with methylphenidate for apathy. African Journal of Pharmacy and Pharmacology Vol. 6(8), pp. 505-507, 29 February, 2012
  26. Nor Zuraida Zainal, Anandjit Singh Kaka Singh, Ng Chong Guan, Rosy Jawan, Jesjeet Singh Gill. 2012. Prevalence of Postpartum Depression in a Hospital Setting among Malaysian Mothers. Asia Pacific Psychiatry 4:144-149
  27. R. Manikam , S.T. Jambunathan, S.K. Pillai, J.S. Gill , K.O. Hui: New-Onset Refractory Status Epilepticus Syndrome (NORSE), Early-Onset Schizophrenia and Possesion: A Clinical Dilemma in the Multicultural Asian Emergency Department Setting. The Internet Journal of Emergency Medicine. 2012 Volume 7 Issue 2
  28. Salina M, Gill JS. Quality of Life of Patients with Epilepsy in Malaysia. Asia Pacific Psychiatry 6 (2014) 105 109
  29. A. Hatim, S. Mas Ayu, H. Habil, M. Mustafa, J. Gill, R. Rusdi, A. Amer Siddiq. 2011. Psychiatric co-morbidity and suicidality among methamphetamine dependent patients who seek treatment in Malaysia. European Neuropsychopharmacology 21(s2):161
  30. Gill JS, Pillai SK, Koh OH et al.Mania secondary to a right arteriovenous malformation. Asia-Pacific Psychiatry 3 (2011) 160 161
  31. Jesjeet Singh Gill, Subash Kumar Pillai, Ong Hui KOH and Stephen Thevanathan JambunaTHan. Low dose Quetiapine in the Treatment of an Adolescent with Somnambulism:A Case Report. Acta Neurologica Belgica.2011, 111, 155-156
  32. Gill, JS; Gee, LH; Wen, TJ; et al.Adherence to metabolic monitoring guidelines in atypical antipsychotic usage. International Journal of Neuropsychopharmacology. 2010 Volume: 13 Pages: 92-93
  33. JS Gill, SK Pillai, OH Koh, ST Jambunathan. Nonfatal Overdose with Paliperidone: A Case Report. Turk Psikiyatri Dergisi. Vol 21(4):331-334
  34. Jambunathan ST, Gill J, Ong Hui Koh, Sulaiman H. 2010 Parkinson Disease and Neuroleptic Withdrawal. Annals of General Psychiatry 2010;9(S1):S223
  35. Jesjeet S Gill,Koh OH,Subash K Pillai. Anxiety Disorders among Incarcerated Drug Users. Malaysian Journal of Psychiatry 2010; (1): online early.
  36. Jesjeet SG, Rusdi AR, Rosy J, Koh OH. History of Drug Use in Malaysia A Review. International Journal of Addiction Sciences, 2010. 1(1):24-29
  37. Jesjeet SG, Salina M. Social Anxiety Among Medical Undergraduate Students in Malaysia. European Psychiatry 2010. 25(S1):
  38. Kanan K, Pillai SK, Gill JS, Hui KO Swami V. Religious beliefs, coping skills and responsibility to family as protective factors against deliberate self-harm. South African journal of Psychiatry. 2010.16(4):139-146
  39. Koh OH, Azreen Hashim N, Jesjeet S Gill, Subash K Pillai. CASE OF POST-STROKE MANIA. Malaysian Journal of Psychiatry. Malaysian journal of Psychiatry
  40. Koh OH, Gill JS, Pillai SK. Evidence-Based Clinical Practice - A Critical Analysis of Its Justification And Limitations. Malaysian Journal of Psychiatry, 2010, 19 (1
  41. Koh, OH; Singh, GJ; Kumar, PS; et al. Choice of antipsychotics prescribed for first episode psychotic patients in a teaching hospital.International Journal of Neuropsychopharmacology. 2010 Volume: 13 Pages: 98-98
  42. Noor Zurani MHR, Jambunathan S, Gill JS. Research, Casuistry and Psychiatry An Asian Perspective. ASEAN Journal of Psychiatry, 2010; 11(1)
  43. Puviarasi M. , Sujaya S, Lau YL , Jesjeet S, Visvaraja S Veeranoot N. Detection of Toxoplasma gondii DNA by PCR following micrwave treatment of serum and whole blood. Southeast Asian Journal of Tropical Medicine and Public Health, 2010 41(2): 265-273
  44. Salina M, Jesjeet SG. Depression and Quality of Life of Patients with Epilepsy in Malaysia. European Psychiatry 2010. 25(S1):
  45. Zainal N. Z.; Gill J. S.; Koh O. H.; et al. Naturalistic observation on effects of antipsychotics on psychopathology and functionality of schizophrenia patients in a single centre in Malaysia. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY.2010 Volume: 13 Supplement: 1 Pages: 113-113
  46. Gill JS, Jambunathan ST et al. The pattern of Use and Outcomes of Asian Patients with Schizophrenia treated with Risperidone over five years. European Neuropsychopharmacology, 2009(19):558
  47. Gill JS, Jawan R. The Psychology of Sodomites. Malaysian Journal of Forensic Pathology and Science. 2009; 3(4): 42-46.
  48. Zuraida NZ, Gill JS, Koh OH et al. Gender Influences on Psychopathology and Functionality in Schizophrenia in University Malaya Medical Centre, Kuala Lumpur, Malaysia. Malaysian Journal of Psychiatry, 2009, 18 (1): 23-26
  49. A Hatim, JS Gill, ST Jambunathan et al. Escitalopram in the Treatment of Malaysian Patients with Obsessive-compulsive Disorder. Hong Kong Journal of Psychiatry, 2008. 18(4):152-157.
  50. AH Sulaiman, JS Gill et al. Subgroup analysis of the Use of Escitalopram in Malaysian patients with obsessive Compulsive Disorder. A Randomised, Double Blind, Placebo-Controlled Trial. The International Journal of Neuropsychopharmacology ,2008,11(1), pp 278
  51. AN Amer Siddiq, Koh Ong Hui, Gill Jesjeet Singh. Early Intervention Centre in The Screening for Bipolar Disorder in Malaysia. Bipolar Disorders, 2008, 10 (S1):48
  52. Jambunathan ST, Jesjeet SG, Sharmilla K. Dissociation or Culture Bound? A Malaysian Perspective. International Journal of Medicine.2008. Vol 1(2): 100-104.
  53. Jambunathan ST, Jesjeet SG, Koh OH. Dissociative identity disorder: an attempt to understand the disorder in Malaysian context. ASEAN Journal of Psychiatry 2008;9 (2):118-125.
  54. KohOH, NA Hashim, Gill JS. Post Stroke Mania: ACase Report. Bipolar Disorders, 2008, 10 (1):48
  55. Salina M, Ng CG, Gill JS et al. Social anxiety symptoms among first to final year medical students in Universiti Malaya Medical Center (UMMC) A cross-sectional study. Malaysian Journal of Psychiatry, 2008, 17 (2): 17-22
  56. Tan TJ, Norzuraida Z, Jesjeet SG et al. Depression and Functional Level in Schizophrenia: A Comparison between Chronic Hospitalised Inpatients and Community Care Patients, JUMMEC, 2008. Vol 10(2):31-36.
  57. AN Amer Siddiq, OH Koh, NZ Zainal, JS Gill. Phenomenological Ethnic Differernces in First Episode Schizophrenia Spectrum Disorder Patients. Australian and New Zealand Journal Of Psychiatry 2007, Vol 41 (2):A486.
  58. Jesjeet SG, Hatim AS, Habil H. The First Methadone Programme in Malaysia: Overcoming Obstacles and Achieving the Impossible. ASEAN Journal of Psychiatry 2007;8 (2):64-70.
  59. Pillai SK, Hatim AS, Jesjeet SG et al. Psychiatric Posting in Final Year Medical Students: Do Attitudes Change. Malaysian Journal of Psychiatry, 2007, 15 (2):26-34.
  60. Hatim A, Habil H, Jesjeet SG, et al. Safety and efficacy of rapid dose administration of quetiapine in bipolar mania. Human Psychopharmacology 2006; 20:313 318..impact factor 2.4
  61. Ebenezer E, Jesjeet SG and Aili A. Outcome Study of Early Onset Schizophrenia in Malaysia. Malaysian Journal of Psychiatry, 2005, 13 (1):20-26.
  62. Gill JS, Jambunathan ST, Muhsin M and Abdul Rashid R. Anticholinergic Exacerbation of Psychotic Symptoms: A Case Report. JUMMEC 2003-2005, Vol 6: 61-62
  63. Gill JS, Koh OH and Jambunathan ST. First Episode Psychosis in A Malaysian Chinese Population. Hong Kong Journal of Psychiatry, 2005,15(2):54-59
  64. Ebenezer E, Hanim A and Gill JS. Outcome Study of Early Onset Schizophrenia in Malaysia. Schizophrenia Research 2004, Vol 70 (1): 81
  65. F Low, S Jambunathan, J Gill, AH Sulaiman. Clozapine and Risperidone: Combination/Augmentation in Treatment Refractory Schizophrenia: A Case Report of 4 Asian Patients. International Journal of Neuropsychopharmacology, 2004, 7(1): 403
  66. Gill JS, Jambunathan ST, Low CC et al. Implementing an Early Intervention Programme That Caters to Needs of The Multicultural Population in Malaysia. Schizophrenia Research 2004, Vol 70 (1): 29
  67. Gill JS, Koh OH and Jambunathan ST. Ethnic Differences in Phenomenology of First Episode Psychosis. Schizophrenia Research 2004, Vol 70 (1): 114
  68. Gill JS, Koh OH, Hatim A and Jambunathan ST. First Episode Psychosis- Cultural Differences in Malaysia. Schizophrenia Research 2004, Vol 70 (1): 81
  69. Jambunathan ST, Gill JS, LowCC, Hatim A. Early Intervention Centre Overcoming Obstacles and Achieving Goals in Malaysia. Schizophrenia Research 2004, Vol 70 (1): 126
  70. Jambunathan ST, Jesjeet SG, Low CC and Jacob J. Dissociative Identity Disorder Is It Bound By Culture. World Psychiatry, 2004, 3 (1):290
  71. Jambunathan ST, Jesjeet SG, Low CC. Indications and Outcome of the Use of Quietiapine in University Malaya Medical Centre. World Psychiatry, 2004, 3 (1): 215
  72. Jesjeet SG, Ng LL, Jambunathan ST and Low CC. The Use of Physical Restraints in Elderly Medically Ill Inpatients: Nurses and Patients Perceptions. World Psychiatry, 2004, 3 (1): 311
  73. Jesjeet SG, NorZuraida Z. Continuing Risk Behaviours In HIV Positive Drug Users. World Psychiatry, 2004, 3 (1): 315
  74. Low CC, Aili A, Stephen J and Jesjeet S. Substance Use Among Juvenile Delinquents At Sekolah Tunas Bakti, Kuala Lumpur. World Psychiatry, 2004, 3 (S1): 327
  75. MA Said, AH Hatim, JS Gill. Diabetes Mellitus, Obesity and Lipid Abnormalities in Schizophrenic Patients Treated with Atypical Antipsychotics. International Journal of Neuropsychopharmacology, 2004, 7(1) 255
  76. Gan CK, Jambunathan ST, Jesjeet SG. Pattern of The Use of Physical Restraints on Psychiatric Inpatients in University Malaya Medical Centre. Malaysian Journal of Psychiatry 2003, 11 (1):24-33.
  77. Jesjeet SG, NorZuraida Z. HIV Risk Behaviours Among Intravenous Drug Users. Malaysian Journal of Psychiatry, 2003, 11 (1):18-23.
  78. Low CC, Jesjeet SG, Jambunathan ST. Steven Johnson Syndrome Without The Usual Suspects A Case Report. Malaysian Journal of Psychiatry 2003, 11 (2): 39-41
  79. Nazrin OM, Jambunathan ST, Jesjeet SG, Aili HH. Adolescent Psychiatric Disorders in The Inpatient Psychiatric Unit of University Malaya Medical Centre. Malaysian Journal of Psychiatry 2003, 11 (2): 34-38
  80. Jesjeet SG, Norharlina B, Toh CL. Restraining of Patients in Female Psychiatric Ward. Kuala Lumpur Hospital Journal of Quality Improvement, 2000, 4(2): 7-12.
  81. Koh OH, Zuraida NZ, Low CC, Jesjeet SG et al. Reasons For Staying Alive in Suicide Attempters Across Different Ethnic Groups Admitted to UMMC. Malaysian Journal of Psychiatry 2002, 10 (2): 40-44
  82. Wong CY, Balakrishna SV, Jesjeet SG et al. Small Bowel Metastasis From Primary Lung Cancer A Case Report and Review of The Literature. Medical Practice Hospital Ipoh, 1997, 3(2):6-9
Books
  1. Psychiatric Emergencies . Handbook for Medical Students. 2nd Edition, Dept of Psychological Medicine, University Malaya 2016
  2. M.H.Habil, R.Abdul Rashid & S.A.Jazaeri.2011.Perspectives of Addiction Medicine in Malaysia.
  3. Norzuraida NZ, Jesjeet SG. Skizofrenia: Penyakit Mental. UM Publishers Kuala Lumpur
  4. Jambunathan ST and Jesjeet SG. Cognitive Behavioural Simplified. 2008, Kuala Lumpur. Lundbeck Malaysia
  5. T. Maniam et al. Malaysian Consensus Statement for the Treatment of Bipolar Disorder. CMP Medica 2007.
  6. Abdul Aziz, Hussain Habil, Adeeba Kamarulzaman,Jesjeet Singh Gill et al. National Methadone Maintenance Therapy Guideline. NCD Ministry of Health, K. Lumpur. Cetakan Pertama, 2005
Article in Proceeding
  1. Amer S, Jesjeet SG. Ethnic Differences in Phenomenology among First Episode Psychosis patients in Malaysia. 6th Lilly Postgraduate Conference, Kuala Lumpur, Malaysia. 15th- 16th September 2006
  2. Jesjeet SG,The Current Issues and Challenges in the management of Schizophrenia. Collegium International Neuropsychopharmacology Pacific Asia Regional Meeting. 2008, Kuala Lumpur. March 2nd 5th 2008.
  3. Lilly Asian Regional Neuroscience Conference, Shangrila Putra Jaya, Malaysia. Depression - Current Treatment Trends . 26th 27th January 2007
  4. Jesjeet SG. Depression in Opioid Maintained Patients. 1st International Conference on Addiction Medicine, Kuala Lumpur. 15th 17th November 2007
  5. Pillai SK, Hatim AS, Jesjeet SG. Psychiatric Posting in Final Year Medical Students: Do Attitudes Change. World Psychiatric Association Regional Congress, Seoul Korea. 18th 21st April 2007.
  6. Hatim A, Habil H, Jesjeet SG, et al. Safety and efficacy of rapid dose administration of quetiapine in bipolar mania. International Schizophrenia Society Conference, Madrid, Spain, December 2006
  7. 7th National Mental Health Convention : Recent Advances in the Management of Bipolar Affective Disorder, Berjaya Hotel, Penang, 26th May 2005
  8. Jambunathan ST, Jesjeet G, Low CC. Recurrent Status Pseudoepilepticus- A Case Analysis from Malaysia. XIIIth World Congress of Psychiatry 2005, Cairo September 10th 15th 2005
  9. Jambunathan ST, Jesjeet G, Thiagu S. Prodromal Symptoms and Duration Of Untreated Illness. XIIIth World Congress of Psychiatry 2005, Cairo September 10th 15th 2005
  10. John Tan, Jesjeet SG. Depression and Functional Level in Chronic Hospitalized Schizophrenia Patients Compared to Community Care. 7th Johor Mental Health Conference, Johor Bahru, July 2005
  11. 11th Scientific Meeting of the Pacific Rim College of Psychiatrists 2004, Hong Kong. Early Psychosis Programmes in the Pacific Rim Region Symposium: Early Psychosis in Asia Pacific
  12. 6th Johor Mental Health Conference Plenary: Training for Bipolar Affective Disorder REACH Programme Hyatt Regency Johor Bahru. 20th May, 2004
  13. Health Worlds Asia 2004 International Health Exhibition and Congress. Special focus on Psychiatry - TREATING THE UNSEEN: Early intervention and General Management in Psychiatry . 2-5 September Putra World Trade Centre, Kuala Lumpur
  14. 1st Penang Mental Health Conference Symposium on `Early Intervention in Psychosis Introduction, Rationale and Evidence . October 2003
  15. Jambunathan ST, Jesjeet SG. A Long Term Study About The Use Of Risperidone In Malaysia. World Psychiatric Association International Congress 2003, Caracas, Venezuela. October 01-04, 2003
  16. Jesjeet SG. Depression, Drug Offenders and the Drug Rehabilitation Centre. 2nd Brunei-Indonesia-Malaysia-Philipines EAGA Regional Mental Health Conference, Sabah, Malaysia. 26th-29th April 2003
  17. Jesjeet SG. Psychiatric Morbidity Among Incarcerated Drug Users. World Psychiatric Association International Congress 2003, Caracas, Venezuela. October 01-04, 2003
  18. Jesjeet SG, See EK. Assault By Patients Towards Nursing Staff. 1st Brunei-Indonesia-Malaysia-Philipines EAGA Regional Mental Health Conference, Sabah, Malaysia. 8th-9th April 2000
  19. Jesjeet SG. HIV Risk Behaviours Among Intravenous Drug Users. 3rd Perak Mental Health Convention, Perak, Malaysia. 13th-14th October 2000
  20. Jesjeet SG, See EK. Are Certain Doctors Jinxed? 4th Malaysian Mental Health Convention, Johor, Malaysia. 30th-31st October 1999.
Other Publications
  1. New Straits Times. Facebook tension for kids. 12/2/2012 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  2. Borneo Post. 1 in 3 elderly abandoned. 7/12/2011 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  3. New Straits Times. ON TRACK TO HEALING 19/8/2011 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  4. New Straits Times. Perversion to cause severe pain. 7/9/2011 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  5. Infopsikik (Musim Ke-dua).RTM - TV2. Mac 2009 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  6. New Strait Times. Teens not mentally ready to raise kids. 5/8/2010 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  7. New Straits Times. Get help early for distressed kin. 18/8/2010 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  8. New Straits Times. Internet revenge after being dumped 21/11/2010 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  9. New Straits Times. Learning about the birds and the bees at an early age may sting. 14/11/2010 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  10. China Press. Pain or depression 25/03/09 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  11. Guang Ming Daily. Unexplained pain is depression masked 29/04/09 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  12. Health Today. Pain and Depression Day Workshop. May 2009 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  13. JELITA. Wanita terdedah kepada kemurungan. April 2009 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  14. KOSMO. Wang punca wanita Malaysia murung. 4. 3.09 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  15. Kemurungan dijangka meningkat. Berita Harian. 19.3.09 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  16. Malay Mail. Depression unmasked. 9/3/09 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  17. Metro Ahad. Topeng murung. 15/3/09 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  18. Mingguan Wanita. AWAS Murung Boleh Dorong BUNUH DIRI. 10.04.09-16.04.09 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  19. Nanyang Siang Pau. Unexplained pain is depression masked190309 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  20. New Straits Times. Depression can be a pain. 17.03.09 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  21. The Star. Pain can mask depression say experts. 4.3.09 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  22. Utusan Malaysia. Kemurungan melanda dalam senyap. 10.3.09 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  23. Alleviating Stress on Flights. Johor Times: What Travellers Want. April 2008, page 4 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  24. Jambunathan ST and Jesjeet SG. Psychological Aspects of Vertigo. In Kuljit Singh (Ed): Handbook of Vertigo for GPs. Sent to UM Publishers - Unpublished Writting Works
  25. Jesjeet SG, Koh OH, Jambunathan ST. Ethnic Differences in First Episode Psychosis Among Different Groups in Malaysia. (Sent for Publication to Early Intervention in Psychiatry Journal) - Unpublished Writting Works
  26. NorZuraida Zainal and Jesjeet Singh Gill. Skizofrenia. Sent to UM Publishers - Unpublished Writting Works
  27. Obsessive Compulsive Disorder & Panic Attack Infopsikik. RTM 2 Mac 2007 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  28. For every 1 treated, 10 go undetected Malay Mail 24 April 2007 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  29. PANSS (Positive and Negative Syndrome Scale) Rating Training Video for Clinical Trials in Schizophrenia. By Ahmad Hatim Sulaiman, Jesjeet Singh Gill and Stephen Jambunathan. Purchased by Lundbeck Pharmaceuticals Asia Medical Research and Development. 2007 - Other Media(Tape,Video,Internet)
  30. Take a Closer Look at your Patient with Schizophrenia- Focus on Treatment Compliance Seroquel Bimonthly Newsletter July 2006 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  31. Anxious in Public Fit for Life, Star Newspaper 1st May 2005. page 11 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  32. Ejakulasi Pramatang, Masalah Lelaki Seminit . Ruangan Kesihatan, Mingguan Malaysia 22 Mei 2005. Mukasurat 25. - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  33. Helping Malaysian Males Guang Min Daily 26th May 2005. page A10 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  34. PE Malukan Lelaki . Ruangan Wanita dan Keluarga, Berita Harian 2 Jun 2005. Mukasurat C6. - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  35. Penyakit Gangguan Dwikutub Kosmo 18 Mei 2005. Mukasurat 18-19 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  36. Saka Sekadar Gangguan Mental . Berita Harian 2 Jun 2005. Mukasurat 12. - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  37. Saka atau Gangguan Bipolar . Majalah Jelita Julai 2005. Mukasurat 204 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  38. What is Premature Ejakulation? Fit for Life, Star Newspaper 12th Jun 2005. page 3 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  39. Jangan Malu Jika ada Masalah Seksual . Ruangan Keluarga, Utusan Malaysia 28 Jun 2005. Mukasurat 13. - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  40. Psychological Medicine Research Unit Community Project (2005): Audio CDs Information Series for Patients & Caregivers. [Depression, Schizophrenia, Sleep Disorders, Dementia, Attention Deficit Hyperactive Disorder, Functionality] By - Sharmilla K, Hussain Habil Jesjeet S. Gill, Stephen Jambunathan, Ahmad Hatim Sulaiman, Ting Joe Hang - Other Media(Tape,Video,Internet)
  41. Carrying on with Life While on Treatment for Addiction . Health Section, China Press 14th Jan 2004. Mukasurat D1 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  42. Kisah Hidupku Episode 13. RTM 1 14th September 2004 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  43. A Clearer Picture of Schizophrenia Fit for Life, Star Newspaper 12th Dec 2004. page 11 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  44. Skizofrenia Wanita Hari Ini. TV3 11th August 2005 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  45. Early intervention decreases risk of psychosis Medical Tribune 15 November 2003 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  46. More GPs to treat Addicts Medical Tribune 15 December 2003. - Mass Media(Newspaper,Radio,Tv,Popular Magazine)

RESEARCH PROJECT

National
  1. 2019 - 2023, Skim Geran Penyelidikan Trans-Displin (TRGS)
    Elucidating The Interaction Between Blastocystis Sp. And Microbial Diversity To Study Its Effect On Healthy Individuals And Patients With Different Stages Of Colorectal Cancer ( Co-Researcher)
  2. 2019 - 2022, Fundamental Research Grant Scheme (FRGS)
    Assessment Of Gut Microbiota Including Blastocystis Sp. In The Early Detection Of Mental Illness ( Co-Researcher)
  3. 2015 - 2018, Private Funding
    Confirmatory Study of DSP-5423P in Patients with Schizophrenia (Phase III) ( Consultant)
  4. 2015 - 2016, Private Funding
    A phase II randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety and tolerability of four orally administrated dose of BI 409306 during a 12-week treatment period in patients with schizophrenia on stable antipsychotic treatment ( Consultant)
  5. 2014 - 2016, Private Funding
    A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of SM-13496 for the Treatment of Bipolar I Depression (Phase III) ( Consultant)
  6. 2012 - 2015, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness)
    Sexual Dysfunction In Women With Major Depressive Disorder On Selective- Serotonin And Noradrenaline Re-uptake Inhibitors (snri) ( Principal Investigator(PI))
  7. 2015 - 2015, Private Funding
    A multicentric multi country cross sectional study in Asian population to assess and describe cognitive dysfunction in MDD Lundbeck, 2015 ( Consultant)
  8. 2014 - 2015, Private Funding
    Efficacy and safety of Tianeptine oral administration in elderly patients suffering from MDD ( Consultant)
  9. 2012 - 2015, Geran Penyelidikan Universiti Malaya (UMRG)
    Sexual Dysfunction In Women With Major Depressive Disorder On Selective- Serotonin And Noradrenaline Re-uptake Inhibitors (snri) ( Principal Investigator(PI))
  10. 2013 - 2014, Private Funding
    Randomized, Double-blind, Parallel-group, Placebo- controlled, Confirmatory Study of SM-13496 (lurasidone HCl) in Patients with Schizophrenia (Phase III) ( Consultant)
  11. 2013 - 2013, Private Funding
    Efficacy and safety of agomelatine (25 mg/day with blinded potential adjustment to 50 mg/day) for 12 weeks in non-depressed out-patients with Generalized Anxiety Disorder. A 12-week randomized, double-blind, versus venlafaxine XR (75 mg/day with blinded potential adjustment up to 225 mg/day), 2-arm parallel groups, international multicenter study (Phase III) ( Consultant)
  12. 2012 - 2013, Private Funding
    A Phase 2, Randomized, Double-blind, Placebo- controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms (Phase II) ( Consultant)
  13. 2009 - 2012, Fundamental Research Grant Scheme (FRGS)
    Sexual Satisfaction Among married Woman ( Principal Investigator(PI))
  14. 2009 - 2009, Short Term Research Fund (Vote F)(PJP)
    Depression in Patients with epilepsy ( Principal Investigator(PI))
  15. 2008 - 2009, Short Term Research Fund (Vote F)(PJP)
    Depression in Patients with Epilepsy ( Principal Investigator(PI))
  16. 2003 - 2008, Lilly Malaysia Sdn Bhd
    Characteristics of patients seeking help through the IVRS System for early detection of mental illnesses ( Principal Investigator(PI))
  17. 2008 - 2008, Jansen Cilag
    An open label prospective trial to explore the tolerability, safety, and efficacy of flexibly dosed Paliperidone ER in Subjects with schizophrenia R076477-SCH-3022 ( -co investigator)
  18. 2006 - 2006
    Depression and Functional Level in Chronic Hospitalized Schizophrenia Patients Compared to Community Care. ( Consultant)
  19. 2004 - 2004, DuoPharma Biotech
    Methadone Hydrochloride Maintenance In Treatment Of Heroin Dependence ( Principal Investigator(PI))
  20. 2004 - 2004, Janssen Cilag
    Diabetes Mellitus, Obesity and Lipid Abnormalities in Schizophrenic Patients Treated with Atypical Antipsychotics. ( Consultant)
  21. 2003 - 2003
    Substance Use Among Juvenile Delinquents At Sekolah Tunas Bakti, Kuala Lumpur ( Consultant)
  22. 2001 - 2002
    Psychiatric Morbidity Among Drug Offenders in a Drug rehabilitation Centre ( Principal Investigator(PI))
  23. 2001 - 2002
    HIV Risk Behaviours Among Intravenous Drug Users ( Principal Investigator(PI))
International
  1. 2016 - 2022, Private Funding
    Confirmatory Study of Dsp-5423p in Patients With Schizophrenia ( Principal Investigator(PI))
  2. 2018 - 2021, Johnson & Johnson Sdn. Bhd.
    A Double -blind, Randomized, Active -controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation ( Co-Researcher)
  3. 2020 - 2021, Allergan Malaysia Sdn. Bhd.
    A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY, AND TOLERABILITY OF CARIPRAZINE IN A DOSE-REDUCTION PARADIGM IN THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA ( Co-Researcher)
  4. 2015 - 2018, Private Funding
    Elevate. A Randomized, Double-Blind, Placebo- Controlled, Confirmatory Study Lurasidone Hcl in AdolescenceWith Schizophrenia ( Consultant)
  5. 2015 - 2017, Private Funding
    A Phase Ii Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate The Efficacy, Safety and Tolerability of Four Orally Administrated Dose of Bi 409306 During a 12-Week Treatment Period in Patients With Schizophrenia On Stable Antipsychotic Treatment ( Consultant)
  6. 2015 - 2017, Private Funding
    A 104 week flexible dose, open label, multicenter, extension study to evaluate the long term safety and effectiveness of lurasidone in peadiatrics subjects ( Principal Investigator(PI))
  7. 2014 - 2016, International Funding
    A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of Sm-13496 For The Treatment of Bipolar I Depression (Phase III ( Consultant)
  8. 2015 - 2016, Private Funding
    Randomized, Double-Blind, Parallel-Group, Placebo- Controlled, Confirmatory Study of Sm-13496 (Lurasidone Hcl) in Patients With Schizophrenia (Phase Iii) ( Consultant)
  9. 2015 - 2016, Private Funding
    A Phase II randomised, double-blinded, placebo-controlled study to evaluate the efficacy, safety and tolerability of four orally administered doses of BI 409306 during a 12 week treatment period in Patients with schizophrenia on stable antipsychotic treatment ( Consultant)
  10. 2010 - 2012, International Funding
    Protocol R092670SCH3009 Safety, Tolerability, and Treatment Response of Paliperidone Palmitate in Subjects with Schizophrenia When Switching from Oral Antipsychotics ( Principal Investigator(PI))
  11. 2010 - 2012, Lundbeck A/S
    A long-term, open-label, flexible-dose, extension study evaluating the safety and tolerability of Lu AA21004 in patients with major depressive disorder Lundbeck A/SNov 2008 Jan 2010 ( Consultant)
  12. 2010 - 2011, Janssen -Cilag
    A prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of Dapoxetine in men with Premature Ejaculation and concomitant Erectile Dysfunction treated with a Phosephodietterase-5 Inhibitor ( Consultant)
  13. 2009 - 2011, Dainippon Sumitomo
    A phase 3 randomized, placebo-controlled clinical trial to study the safety and efficacy of 3 doses of Lurasidone HCL in acutely psychotic patients with schizophrenia ( Consultant)
  14. 2009 - 2010, Johnson & Johnson
    A randomized, double-blind, placebo and active controlled, parallel-group study to evaluate the efficacy and safety of 3 fixed doses of JNJ-37822681 administered twice daily in subjects with schizophrenia ( Consultant)
  15. 2008 - 2008, lUNDBECK
    Randomized, double blind, parallel group, placebo-controlled, duloxetine referenced dose finding study of LuAA24530 in Major Depression. ( -co investigator)
  16. 2007 - 2008, W.H.O. Collaboration Project
    Evaluation of Disability and Functioning amongst Patients With Depression Using International Classification of Functioning, Disability and Health (ICF) Core Sets ( Consultant)
  17. 2005 - 2006, Lundbeck
    A Pharmacoeconomic Study Conducted in Parallel With Clinical Trial 10199, A Randomized, Double Blind, Flexible Dose Study Evaluating the Efficacy and Safety of 6 Months Treatment With Bifeprunox or Risperidone In Patients With Schizophrenia (10224) and A Pharmacoeconomic Study Conducted in Parallel With Clinical Trial 10200, A 6 Months Double Blind, Risperidone Referenced, Flexible Dose, Parallel-Group, Extension Study of Bifeprunox In Patients With Schizophrenia (10225) - Co Investigator (Sponsor/Grant from ) ( Consultant)
  18. 2005 - 2006, GlaxoSmithKline
    An Open Label Prospective Study to Assess the Efficacy, Safety and Tolerability of 36 weeks Lamotrigine in the Prevention of Mood Episodes in subjects with Bipolar Disorder, who are in Remission, Following a Manic / Hypomanic Index Episode or a Depressive Index Episode (SCA101469) ( Consultant)
  19. 2005 - 2006, Lundbeck
    A Double Blind Randomized, Multicenter, Fixed-dosed Study Comparing the Efficacy of Escitalopram (20mg/day) versus Citalopram (40mg/day) in Patients with Major Depressive Disorder (10796) (Sponsor/Grant from Lundbeck) ( Consultant)
University
  1. 2021 - 2023, NOVARTIS CORPORATION (M) SDN. BHD.
    A double-blind, placebo-controlled, randomized dose-ranging trial to investigate efficacy and safety of in-travenous MIJ821 infusion in addition to comprehensive standard of care on the rapid reduction of symptoms of Major Depressive Disorder in subjects who have suicidal ideation with intent ( Co-Researcher)
  2. 2017 - 2021, JANSSEN, A DIVISION OF JOHNSON & JOHNSON SDN. BHD.
    An open-label long term extension safety study of intranasal esketamine in treatment-resistant Depression ( Co-Researcher)
  3. 2008 - 2009, UM
    Depression in Epeliptic Patients in UMMC ( Principal Investigator(PI))
  4. 2006 - 2006, NIL
    Psychiatric Posting in Final Year Medical Students: Do Attitudes Change ( Consultant)
  5. 2005 - 2005, Astra Zeneca International Research and development
    An Open Trial Examining the Safety, Efficacy and Tolerability of Fast Titration of Quetiapine Fumarate in the treatment of Bipolar I Manic Episode ( Consultant)
  6. 2005 - 2005
    Recurrent Status Pseudoepilepticus- An Analysis of cases ( Consultant)
  7. 2003 - 2004, UM
    Characteristics of patients Presenting with First Episode Psychosis ( Principal Investigator(PI))
  8. 2004 - 2004
    Prodromal Symptoms and Duration Of Untreated Illness. ( Principal Investigator(PI))
  9. 2004 - 2004
    The Use of Physical Restraints in Elderly Medically Ill Inpatients ( Consultant)
  10. 2004 - 2004
    Indications and Outcome of the Use of Quietiapine in University Malaya Medical Centre ( Consultant)
  11. 2003 - 2003
    Pattern of Use of Physical Restraints on Psychiatric Inpatients ( Consultant)
  12. 2000 - 2003
    A Long Term Study About The Use Of Risperidone In Malaysia. ( Consultant)
  13. 2003 - 2003
    Adolescent Psychiatric Disorders in The Inpatient Psychiatric Unit ( Consultant)

CONSULTANCY PROJECT

  • A Multicenter, Active-Controlled, Double-Blind Parallel Group-Comparison Trial to Investigate The Efficacy and Safety of Aripiprazole Im Depot (Opc-14597imd) Compared With Aripiprazole Tablets in Patients With Schizophrenia, Otsuka Pharmaceutical Co. Japan
    01 Dec 2013 - 01 Dec 2019 (International)
  • A 104 Week Flexible Dose, Open Label, Multicenter, Extension Study to Evaluate The Long Term Safety and Effectiveness of Lurasidone in Peadiatrics Subjects, Dainippon
    01 Nov 2015 - 01 Nov 2017 (International)
  • Cofirmatory Study of Dsp-5423p in Patients With Schizophrenia (Phase 3), Sumitomo Dainipon Pharma Co. Japan
    01 Dec 2015 - 01 Dec 2017 (International)
  • A Phase Ii Randomised, Double-Blinded, Placebo-Controlled Study to Evaluate The Efficacy, Safety and Tolerability of Four Orally Administered Doses of Bi 409306 During a 12 Week Treatment Period in Patients With Schizophrenia On Stable Antipsychotic Treatment, Boehringer Ingelheim
    01 Dec 2015 - 01 Dec 2016 (International)
  • A Phase 3, Multicenter, Extension Study of Study Alk9072-003ext2 to Assess The Long Term Safety and Durability of Effect of Alks 9072 in Subjects With Stable Schizophrenia, Alkermes Inc, MA, USA
    01 Dec 2014 - 01 Dec 2016 (International)
  • A Long Term, Phase 3, Multicenter, Open Label Trial to Evaluate The Safety and Tolerability of Oral Opc-34712 as Maintenance Treatment in Adults With Schizophrenia, Otsuka Pharmaceuticals Japan
    01 Dec 2013 - 01 Dec 2016 (International)
  • A Long-Term Study of Sm-13496 in Patients With Bipolar I Disorder (Phase III), Sumitomo Dainipon Pharma Co. Japan
    01 Dec 2014 - 01 Dec 2016 (International)
  • A Long Term Study of Sm-13496 in Patients With Bipolar I Disorder, Dainippon Sumitomo Pharma Japan
    01 Dec 2015 - 01 Dec 2016 (International)
  • 3. a Phase Ii Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate The Efficacy, Safety and Tolerability of Four Orally Administrated Dose of Bi 409306 During a 12-Week Treatment Period in Patients With Schizophrenia On Stable Antipsychotic Treatment (Phase Ii) (Mar 2015 Present) Bi, Boehringer Ingelheim
    01 Dec 2015 - 01 Dec 2016 (International)
  • A 6-Week Randomized, Parallel, Double Blind, Placebo Controlled, Fixed Dose, Multicenter Study to Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia, Sunovion Pharmaceuticals Inc, New Jersey, USA
    01 Dec 2014 - 01 Dec 2016 (International)
  • Efficacy and Safety of Tianeptine Oral Administration in Elderly Patients Suffering from Mdd, Servier, France
    01 Dec 2014 - 01 Dec 2015 (National)
  • A Multicentric Multi Country Cross Sectional Study in Asian Population to Assess and Describe Cognitive Dysfunction in Mdd, Lundbeck
    01 Dec 2014 - 01 Dec 2015 (International)
  • A Multicenter, Randomized, Double Blind Trial to Assess The Efficacy and Safety of Asc-01 in Patients With Major Depressive Disoreder, Otsuka Pharmaceutical Co. Japan
    01 Dec 2014 - 01 Dec 2015 (International)
  • Efficacy and Safety of Agomelatine (25 Mg/Day With Blinded Potential Adjustment to 50 Mg/Day) for 12 Weeks in Non-Depressed Out-Patients With Generalized Anxiety Disorder. a 12-Week Randomized, Double-Blind, Versus Venlafaxine Xr (75 Mg/Day With Blinded Potential Adjustment Up to 225 Mg/Day), 2-Arm Parallel Groups, International Multicenter Study (Phase III), Servier, France
    01 Dec 2013 - 01 Dec 2014 (International)
  • A Randomized, Double Blind, Placebo and Active-Controlled, Parallel Group Study to Evaluate The Efficacy and Safety of 3 Fixed Doses of Jnj-37822681 Administered Twice Daily in Subjects With Schizophrenia, Johnson and Johnson
    01 Dec 2010 - 01 Dec 2012 (International)
  • Safety, Tolerability, and Treatment Response of Paliperidone Palmitate in Subjects With Schizophrenia When Switching from Oral Antipsychotics, jOHNSON AND jOHN SON
    01 Apr 2011 - 01 Apr 2011 (International)
  • Safety, Tolerability, and Treatment Response of Paliperidone Palmitate in Subjects With Schizophrenia When Switching from Oral Antipsychotics, Otsuka
    01 Apr 2011 - 01 Apr 2011 (International)
  • Alpha Study - Phase 3 Randomised Double Blind Trial of Im Depot Aripripazole Vs Placebo, Otsuka
    01 Apr 2011 - 01 Apr 2011 (International)
  • Safety, Tolerability, and Treatment Response of Paliperidone Palmitate in Subjects With Schizophrenia When Switching from Oral Antipsychotics, jOHNSON AND jOHN SON
    01 Apr 2011 - 01 Apr 2011 (International)
  • A 8-Week Randomized, Double-Blind, Parallel Group, Phase III Study of The Efficacy and Safety of Agomelatine Versus Fluoxetine in Outpatients With Major Depressive Disorder (Cl3-20098-052), Servier
    01 Nov 2006 - 01 Nov 2008 (International)
  • Protocol R076477-Bim-3004. a Randomized, Double Blind, Active and Placebo-Controlled, Study to Evaluate The Efficacy and Safety Paliperidone Er as a Maintenance Treatment After An Acute Manic or Mixed Episode Associated With Bipolar I Disorder, Jansssen-Cilag
    01 Nov 2005 - 01 Nov 2008 (International)
  • A Randomized, Double Blind, Flexible Dose Study Evaluating The Efficacy and Safety of 6 Months Treatment With Bifeprunox or Risperidone in Patients With Schizophrenia (10199) and a 6 Months Double Blind, Risperidone Referenced, Flexible Dose, Parallel-Group, Extension Study of Bifeprunox in Patients With Schizophrenia (10200), -Lundbeck
    01 Nov 2008 - 01 Nov 2008 (International)
  • A Multicenter, Double Blind, Randomized, Parallel-Group Active and Placebo-Controlled, Phase III Study to Evaluate The Efficacy and Safety of Queitiapine Fumarate as Monotheraphy in The Treatment of Adult Patients With Major Depressive Disorder (D1446c00004), Aztra Zeneca
    01 Nov 2005 - 01 Nov 2007 (International)
  • A Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Dose Response Study to Evaluate The Efficacy and Safety of 3 Fixed Dosages of Extended Release Oros Paliperidone (3,9, and 15mg/Day) and Olanzapine (10mg/Day), With Open Label Extension, in The Treatment of Subjects With Schizophrenia, Jansssen-Cilag
    01 Nov 2005 - 01 Nov 2007 (International)
  • Protocol No.: 11613a; (a Double-Blind, Randomised, Parallel Group, Placebo-Controlled Study of The Safety, Tolerability and Efficacy Following Sequential Dose Regimens of Lu 31 -130 to Male Patients With Schizophrenia., Lundbeck
    01 Nov 2006 - 01 Nov 2007 (International)
  • Protocol No.: 11492a; (Double-Blind, Randomised, Placebo-Controlled Study Comparing The Efficacy and Safety of Two Fixed Doses of a Novel Antidepressant Compound to That of Placebo in Patients With Major Depressive Disorder. - Co Investigator (Sponsor/Grant from ), Lundbeck
    01 Nov 2006 - 01 Nov 2007 (International)
  • Protocol No.: 11613a; (a Double-Blind, Randomised, Parallel Group, Placebo-Controlled Study of The Safety, Tolerability and Efficacy Following Sequential Dose Regimens of Lu 31 -130 to Male Patients With Schizophrenia., Lundbeck
    01 Nov 2006 - 01 Nov 2007 (International)
  • Sertindole Versus Risperidone Safety Outcome Study: a Randomised, Partially Blind, Parallel-Group, Active-Controlled, Post Marketing Study (Scop 99824), Lundbeck
    01 Nov 2004 - 01 Nov 2007 (International)
  • A 6-Week Multicenter, International, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase Iiib Study of The Efficacy and Safety of Queitiapine Fumarate Immediate Release Tablets in Daily Doses of 400mg and 800mg Compared With Placebo in The Treatment of Adolescents With Schizophrenia (D1441c00112), Astra Zeneca
    01 Nov 2007 - 01 Nov 2007 (International)
  • Exploration of in Vitro/in Vivo Correlation of Paliperidone Palmitate Long Acting Formulation (Phase 1), Jansssen-Cilag
    01 Nov 2005 - 01 Nov 2006 (International)
  • A Randomized, Double Blind, Placebo Controlled Study to Explore The Efficacy and Safety of Risperidone Long Acting Intramuscular Injectables in The Prevention of Mood Episodes in Bipolar I Disorder, Jansssen-Cilag
    01 Nov 2005 - 01 Nov 2006 (International)
  • An International, Multicenter, Large Simple Trial (Lst) to Compare The Cardiovascular Safety of Ziprasidone and Olanzapine, Pfizer
    01 Nov 2005 - 01 Nov 2006 (International)
  • Efficacy of Monotheraphy Seroquel in Bipolar Depession Embolden, Astra Zeneca
    01 Nov 2005 - 01 Nov 2006 (International)
  • A Placebo Controlled,Double Blind, Randomized, Parallel Group Study of The Efficacy and Safety of Dapoxetine in The Treatment of Men With Premature Ejaculation, Johnson and Johnson
    01 Nov 2005 - 01 Nov 2006 (International)
  • Multicenter Randomised Parallel Group, Double Blind, Placebo Controlled, Phase III Study of The Efficacy and Safety of Quietiapine Fumarate and Lithium as Monotherapy in 28-104 Weeks Treatment of Bipolar 1 Disorder in Adult Patients., Quintiles East Asia
    01 Nov 2005 - 01 Nov 2006 (International)
  • A Double Blind Randomized, Placebo-Controlled Relapse Prevention Trial With 10-20mg Escitalopram in Obsessive Compulsive Disorder (10193), Lundbeck
    01 Nov 2005 - 01 Nov 2006 (International)
  • A 12-Week, International, Multicenter, Open Label, Non-Comparative Study to Evaluate The Feasibility of Switching Any Antipsychotic Treatment to Sustained-Release Quietiapine Fumarate (Seroquel) in Patients With Schizophrenia, Quintiles East Asia
    01 Nov 2005 - 01 Nov 2006 (International)
  • A Phase III Randomized, Placebo Controlled, Double Blind Trial, Evaluating The Efficacy and Safety of of Sublingual Asenapine Vs Olanzapine and Placebo in in-Patients With An Acute Mania Episode, Pfizer
    01 Nov 2005 - 01 Nov 2006 (International)
  • A Randomized, Double Blind Trial, Placebo Controlled Study to Evaluate The Efficacy and Safety of Paliperidone Palmitate in Subjects With Schizophrenia, Jansssen-Cilag
    01 Nov 2005 - 01 Nov 2006 (International)
  • A Double Blind Randomized, Multicenter, Fixed-Dosed Study Comparing The Efficacy of Escitalopram (20mg/Day) Versus Citalopram (40mg/Day) in Patients With Major Depressive Disorder, Lundbeck Asia
    01 Nov 2005 - 01 Nov 2005 (International)

PAPER PRESENTED

PLENARY SPEAKER
  1. Starting treatment on a newly diagnosed psychiatric patient: Physicians considerations beyond the direct cost of treatment, The 4th Asia Pacific Psychiatry Symposium, Luye Pharma (International) (25 Jun 2022 - 25 Jun 2022)
  2. COMORBIDITY AND ADDICTION, MENTAL HEALTH AND ADDICTION CONFERENCE 2021, UMCAS (National) (27 Aug 2021 - 29 Oct 2021)
  3. Tailoring Treatment in Schizophrenia with Solian, 20th Johor Mental Health Convention, Hospital Permai (National) (04 Sep 2018 - 06 Sep 2018)
  4. Incorporating Atypical AP in Treatment Resistant Depression, 19th Johor Mental Health Convebtion, Hospital Permai (National) (18 Apr 2017 - 19 Apr 2017)
  5. Adherence in Schizophrenia, J&J Regional Conference on Schizophrenia, Johnson & Johnson (International) (12 Jun 2011 - 13 Feb 2011)
  6. Clinical Trial Experience in a Developing Country - Breaking New Grounds, Philippines College of Psychopharmacology Annual Congress. Manila, Philipines, 3rd to 5th December., Philippines College of Psychopharmacology  (International) (03 Dec 2009 - 05 Dec 2009)
INVITED SPEAKER
  1. Re-embracing Life: Broad Spectrum of Schizophrenia, Malaysia Military Medicine Conference 2022, Ministry of Defence (National) (14 Sep 2022 - 14 Sep 2022)
  2. PARADIGM SHIFT IN THE TREATMENT OF MDD: FROMSYMPTOM REDUCTION TO FULL FUNCTIONAL RECOVERY, BRILLIANT POSSIBILITIES MDD WORKSHOP, LUNDBECK MALAYSIA (National) (13 Aug 2022 - 14 Aug 2022)
  3. RETHINKING MANAGEMENT OF BIPOLAR DISORDER - dIAGNOSIS AND TREATMENT, JOHOR MENTAL HEALTH CONVENTION, HOSPITAL PERMAI DAN NEWCASTLE UNIVERSITY (National) (20 Jul 2022 - 21 Jul 2022)
  4. The role of LAI in the treatment of Schizophrenia, Hospital Sungai Buloh CME, Lundbeck Malaysia (National) (01 Jul 2022 - 01 Jul 2022)
  5. Abilify Maintena: The role of LAI in the treatment of Schizophrenia, Hospital Kangar CME, Lundbeck Malaysia (National) (28 Jun 2022 - 28 Jun 2022)
  6. A PARADIGM SHIFT IN THE TREATMENT OF SCHIZOPHRENIA, LUNBECK - OTSUKA NEUROSCIENCE SYMPOSIUM 2022, LUNBECK MALAYSIA (National) (11 Jun 2022 - 12 Jun 2022)
  7. PROGRAM LATIHAN PSIKIATRI DAN SILIBUS PSIKIATRI DI MALAYSIA, PENERANGAN NEW NATIONAL POSTGRADUATE CURRICULUM (PSYCHIATRY) PERINGKAT NEGERI SARAWAK, JAWATANKUASA KEPAKARAN PSIKIATRI MALAYSIA (National) (14 Apr 2022 - 14 Apr 2022)
  8. Focus on Schizophrenia Management Updates, NEXT Step ASEAN, Mitsubishi Tanabe (International) (05 Mar 2022 - 05 Mar 2022)
  9. BROAD SPECTRUM EFFICACY OF CARIPRAZINE IN SCHIZOPHRENIA, RE EMBRACING LIFE EXPERT SEMINAR, MITSUBISHI TANABE (National) (26 Feb 2022 - 26 Feb 2022)
  10. Real World Evidence and Benefits of Seroquel XR, Luye Pharma Workshop for SEA, Luye Pharma (International) (24 Feb 2022 - 24 Feb 2022)
  11. PROGRAM LATIHAN PSIKIATRI DAN SILIBUS PSIKIATRI DI MALAYSIA, SESI PENERANGAN NEW NATIONAL POSTGRADUATE CURRICULUM (PSYCHIATRY) PERINGKAT ZON UTARA, JAWATANKUASA KEPAKARAN PSIKIATRI MALAYSIA (National) (16 Feb 2022 - 17 Feb 2022)
  12. CARIPRZINE SAFETY PROFILE, SYMVENU WEBINAR, MITSUBISHI TANABE (National) (06 Oct 2021 - 06 Oct 2021)
  13. RE EMBRACE LIFE: TREATING TREATMENT GAPS LEADING TO BETTER OL, CARIPRAZINE REGIONAL WEBINAR, MITSUBISHI TANABE (International) (30 Aug 2021 - 30 Aug 2021)
  14. ASIA PACIFIC EXPERIENCE, CLINICAL CASES IN MANAGING MENTAL DISORDERS, OTSUKA JAPAN (International) (29 Jul 2021 - 29 Oct 2021)
  15. Bipolar in pregnancy, Future Experts Training (FET) Seminar (Virtual), Malaysian psychiatry association (National) (29 May 2021 - 29 May 2021)
  16. Managing Depression in Primary Care., 2nd FPMPAM / IPH Annual Convention, 15th 16th September 2018 Kuala Lumpur, FPMPAM / IPH (National) (15 Sep 2018 - 16 Sep 2018)
  17. Male Sexual Dysfunction and Depression, Depression Master Class VII Workshop: Meet the Experts, Servier Malaysia (National) (21 Apr 2018 - 22 Apr 2018)
  18. Tailoring treatment to patient profile, Northern Region Schizophrenia Workshop (Workshop), Sanofi Malaysia (National) (16 Nov 2017 - 16 Nov 2017)
  19. Initial experience sharing based on clinical trial, Priority and Preference of Patient with Schizophrenia, Lundbeck Malaysia (National) (21 Oct 2017 - 21 Oct 2017)
  20. Tailoring treatment to patients profile, Perak Region Schizophrenia Workshop, Sanofi Malaysia (University) (14 Oct 2017 - 14 Oct 2017)
  21. Treatment of Schizophrenia and its side effects. , 20th Malaysian Congress of Psychological Medicine, Malaysian Psychiatric Association (National) (02 Jun 2016 - 04 Jun 2016)
  22. Case study on depression, Pfizer Regional Train the trainer workshop , Pfizer (International) (24 Dec 2015 - 26 Dec 2015)
  23. When to start LAI in Schizophrenia, Return to Work workshop , Jansenn Cilag (University) (12 Dec 2015 - 12 Dec 2015)
  24. Depression in Schizophrenia, Psychiatry In Action Workshop . , MSD (National) (06 Jun 2015 - 07 Jun 2015)
  25. Clinical Profile of Saphris, Asenapine Antipsychotic Workshop , Lundbeck Malaysia (National) (12 May 2012)
  26. Long Acting Injectable Antipsychotics, Hospital Tengku Ampuan Afzan CME, Jabatan Psikiatri, Hospital Tengku Ampuan Afzan (National) (05 May 2012)
  27. Circadian Rhythm and Depression , Agomelatine Workshop, Servier, Malaysia (National) (09 Apr 2012)
  28. Pain and Depression. 19th October 2011, Hospital Kangar Psychiatry CME Pain and Depression, Hospital Kangar (National) (19 Oct 2011)
  29. Vadoxan in Depression. , Jabatan Psikiatri, Hospital Penang CME , Jabatan Psikiatri, Hospital Penang (National) (26 Aug 2011)
  30. Paliperidone in Schizophrenia., Ipoh Mental Health Conference , Jabatan Psikiatri, Hospital Ipoh (National) (26 Feb 2011 - 27 Feb 2011)
  31. Depression: Remission is the Goal, Hospital Sentosa, Kuching, CME, Sarawak. 22 Disember 2009, Hospital Sentosa, Kuching (National) (22 Dec 2010)
  32. Psychiatric disorders and Violence & Non Pharmacological Management of Violence, Johor Mental Health Pre Congress Workshop, Hospital Permai, Johor (National) (01 Jun 2010)
  33. Burden of Depression and Anxiety: GP s role., MMA Dinner Symposium (Pfizer) Petaling Jaya, 8th May 10, 2010, Pfizer (National) (08 May 2010)
  34. Sertindole Case Studies, 2010 Malaysian Psychiatric Association-Lundbeck Neuroscience Symposium, 9-11 April 2010, Penang., Malaysian Psychiatric Association-Lundbeck  (National) (09 Apr 2010 - 12 Apr 2010)
  35. Neurobiology of Depression, Neurobiology of Depression. International Society of Bipolar Disorders (Malaysian Chapter) 1st National Conference, International Society of Bipolar Disorders (Malaysian Chapter) (National) (14 Mar 2010)
  36. Management of metabolic syndrome in schizophrenia., Pfizer Neuroscience Summit 2010. Port Dickson14-16 May 2010, Pfizer (National) (14 Mar 2010 - 16 May 2010)
  37. Olanzapine in the Maintainence treatment of BPD. , International Society of Bipolar Disorders (Malaysian Chapter) 1st National Conference. Putrajaya, 13th March 2010., International Society of Bipolar Disorders (Malaysian Chapter).  (National) (13 Mar 2010)
  38. Treating Schizophrenia with Seroquel and Future Directions , Hospital Tuanku Ampuan Rahimah Kelang CME, Hospital Tuanku Ampuan Rahimah Kelang (National) (10 Feb 2010)
  39. The Acute Efficacy and Safety of Seroquel Extended Release: From Clinical Evidence to clinical Practice , Hospital USM, Kubang Kerian CME, Hospital USM, Kubang Kerian, Kelantan (National) (07 Feb 2010)
  40. Psychiatric disorders and Violence & Non Pharmacological Management of Violence. , Violence Intervention Programme Hospital Pulau Pinang. 30 Oct 2009, Hospital Pulau Pinang (National) (30 Oct 2009)
  41. Pyschosexual Counseling 101: Asking the Right Questions , Erectile dysfunction Train the Trainer Workshop. , Pfizer Malaysia (National) (25 Apr 2008 - 27 Apr 2008)
  42. Psychiatry Evaluation in Vertigo., Symposium on Vertigo Management. , Malaysian Society of Otorhinolaryngologists and Head and Neck Surgeons. (National) (22 Mar 2008 - 22 Mar 2008)
  43. Interactive Case Discussion on Sexual Dysfunction andErectile Dysfunction, Treatment of Erectile Dysfunction and Sexual Satisfaction, Lilly Malaysia (National) (09 Mar 2008)
  44. The Ups and Downs of Bipolar Disorder, The 6th Perak Mental Health Convention., Hospital Bahagia Ulu Kinta (National) (15 Sep 2006 - 16 Sep 2006)
  45. Workshop on New Advances in the management Of Bipolar Disorders, Workshop on New Advances in the management Of Bipolar Disorders. , MPA / Astra Zeneca (National) (29 Jan 2005)
  46. Managing Sleep Disorder in Primary Care, Medical Updates for Primary Care Practitioner , Malaysian Medical Association, Selangor Branch  (Others) (10 Oct 2004)
  47. Methadone Maintenance Treatment, MMA 7th GP Course in the Treatment of Substance Abuse & Addiction , MMA (National) (25 Sep 2004 - 26 Sep 2004)
  48. Managing Sleep Disorders in Primary Care, GP Workshop on Updates on Cardiovascular Diseases , Sanofi-Synthelabo (Malaysia) (National) (27 Aug 2004 - 31 Aug 2004)
  49. Managing Sleep Disorders in Primary Care, GP Workshop on Updates on Cardiovascular Diseases and Sleep Disorders , Sanofi-Synthelabo (Malaysia) (National) (23 Jul 2004 - 25 Jul 2004)
  50. Methadone Maintainence Treatment, MPA Seminar On Managing Heroin Dependence Syndrome , Malaysian Psychiatric Assoc. (National) (11 Apr 2004)
  51. i.Managing Tired and Unmotivated Depressed Patients ii.Signs and Symptoms of Early Psychosis , Primary Care Workshop On Depression and Early Psychosis. , Universiti Sains Malaysia (National) (08 Apr 2004)
  52. Methadone Maintenance Treatment, 53.MMA 6th GP Course in the Treatment of Substance Abuse & Addiction . . 7-8th February 2004, MMA (National) (07 Feb 2004 - 08 Feb 2004)
ORAL PRESENTER
  1. Transforming clinical data into real-world practice, Schizophrenia Masterclass, LUNDBECK MALAYSIA (National) (25 Jun 2022 - 25 Jun 2022)
  2. The Role of Monthly Treatment in Schizophrenia and Bipolar Disorder, Virtual Lunch CME Session, 15 Oct 2021, Hospital Tengku Ampuan Afzan, Lundbeck (National) (15 Oct 2021 - 15 Oct 2021)
  3. The Role of Monthly Treatment in Schizophrenia and Bipolar Disorder, Virtual Lunch CME Session Hospital Selayang, Lundbeck (National) (07 Oct 2021 - 07 Oct 2021)
  4. The Role of Monthly Treatment in Schizophrenia and Bipolar Disorder, Virtual Lunch CME Session Southern Region, Lundbeck (National) (06 Oct 2021 - 06 Oct 2021)
  5. The Role of Monthly Treatment in Schizophrenia and Bipolar Disorder, Virtual Lunch CME Session Northern region, Lundbeck (National) (23 Sep 2021 - 23 Oct 2021)
  6. The Role of Monthly Treatment in Schizophrenia and Bipolar Disorder, melaka Virtual Lunch CME Session, Lundbeck (National) (17 Sep 2021 - 17 Oct 2021)
  7. the Role of Desvenlafaxine in the Current pandemic, PPUM Virtual CME Session, Pfizer (University) (05 Aug 2021 - 05 Aug 2021)
  8. Evidence Based Review of Pharmacological Treatment of Depression, Virtual CME, Servier (University) (08 Jul 2021 - 08 Jul 2021)
POSTER PRESENTER
  1. Co-morbid anxiety disorders in outpatients with schizophrenia: prevalence and relationship to functionality and quality of life, 31st ECNP Congress of Applied and Translational Neuroscience , European College of Neuropsychiatry  (International) (06 Oct 2018 - 09 Oct 2018)
  2. Correlates and Prevalence of Anxiety Disorders among Women with Polycystic Ovarian Syndrome: A Cross Sectional Study. , European Psychiatric Association International Congress, Nice, France, European Psychiatric Association (International) (03 Mar 2018 - 05 Mar 2018)
  3. 3.Depressive Disorders and Sexual Functioning among Malaysia Women with Polycystic Ovarian Syndrome: A Cross Sectional Study, European Psychiatric Association International Congress, European Psychiatric Association  (International) (03 Mar 2018 - 05 Mar 2018)
  4. Adherence to metabolic monitoring guidelines in atypical antipsychotic usage., XXVII International College of Neuropsychopharmacology (CINP) Congress, Hong Kong, 6-10 June 2010, International College of Neuropsychopharmacology  (International) (06 Jun 2010 - 10 Jun 2010)
  5. Social Anxiety among Medical Undergraduate Students in Malaysia. , European Psychiatric Association 18th European Congress of Psychiatry , European Psychiatric Association  (International) (27 Feb 2010 - 03 Mar 2010)
  6. The pattern of Use and Outcomes of Asian Patients with Schizophrenia treated with Risperidone over five years., 22nd ECNP Congress, 12-16 September 2009, ., European College of Neuropsychopharmacology (International) (12 Sep 2009 - 16 Sep 2009)
PRESENTER
  1. Optimising Care in Schizophrenia., Promoting Recovery in Mental Illness Workshop, Pullman Hotel Kuching, Sarawak. 22nd Septemer 2018, Malaysian Psychiatric Association (National) (22 Sep 2018 - 22 Oct 2018)
  2. Early Intervention. , PRIME 2.0 Workshop (Promoting Recovery in Mental Illness, 21st July 2018, Malaysian Psychiatric Association (National) (21 Jul 2018 - 21 Oct 2018)
  3. Restraint and Seclusin in Malaysia, 104th Annual meeting of the Japanese Society of Psychiatry and Neurology, Japanese Society of Psychiatry and Neurology (International) (27 May 2008 - 31 May 2008)
  4. CBT for Depression and Anxiety, Cognitive Behavioural Therapy Workshop for Depression, Anxiety and Substance Abuse , UMMC & Lundbeck  (National) (20 May 2007)
  5. Improving Clinical Outcome of Bipolar Disorder through Research , The 2nd Malaysian Young Psychiatrists Neuroscience Workshop and Annual General Meeting 2007., Malaysian Psychiatric Association, Section of Young Psychiatrist (National) (23 Mar 2007)
  6. Complications of Methadone, MPA Advance course on Methadone Maintenance Therapy , Malaysian Psychiatric Assoc. (National) (05 Dec 2006)
  7. Long Term Study of Efexor XR and Managing Anxiety in Outpatient, Workshop on Prevention of Relapse & Recurrence: Road to Recovery , Wyeth (National) (23 Jun 2006)
  8. Comorbidity of Bipolar Disorder, Workshop on Clinical Management of Psychiatric Disorders , GlaxoSmithKline (National) (15 Jun 2006)
  9. WorkshopAssessing and managing bipolar diosorders, Clinical Management of Psychiatric Disorders , Malaysia Psychiatric Association (National) (30 Apr 2006)
  10. CBT for DEpression and Anxiety, Cognitive Behavioural Therapy Workshop for Depression, Anxiety and Substance Abuse , UMMC & Lundbeck  (University) (25 Apr 2006)
  11. Case Scenarios in Sleep Disorders, Sleep Disorders Workshop:, Malaysian Sleep Society (National) (22 Apr 2006)
  12. CBT in Depression and Anxiety, Cognitive Behavioural Therapy Workshop for Depression, Anxiety and Substance Abuse, UMMC & Lundbeck (National) (27 Feb 2005)
  13. Bipolar or Unipolar Depression?, 44th Malaysian Medical Association Annual General Meeting: , Malaysian Medical Association  (National) (28 May 2004 - 30 May 204)
  14. Update on Heroin Dependence- Methadone Therapy, 6th Johor Mental Health Conference Pre Convention Workshop: Update on Heroin Dependence- Methadone Therapy , Hospital permai (National) (20 May 2004)
  15. Methadone Maintenance Treatment , Seminar On Managing Heroin Dependence Syndrome Using , Malaysian Psychiatric Assoc. and Duopharma Biotech. (National) (06 May 2004)
  16. Addressing Diagnostic Issues, Workshop On Management Of Mood Disorder -Clinical Issues II , Astra Zeneca (National) (09 Apr 2004)
  17. Causes of Insomnia, MMA Selangor and MPA Workshop on Managing Primary Insomnia 7th March 2004, MMA Selangor and MPA (Others) (07 Mar 2004)
  18. Epidemiology of Depression, Malaysian Psychiatric Association Workshop On Depression For The General Practioners in Kuala Lumpur , Malaysian Psychiatric Association (Others) (19 Jul 2003 - 20 Jul 2003)
  19. Epidemiology of Depression, Malaysian Psychiatric Association Workshop On Depression For The General Practioners in Selangor , Malaysian Psychiatric Association (Others) (05 Jul 2003 - 06 Jul 2003)
  20. Anxiety Disorders , 2nd Psychiatric Education Programme for Inpatient Service Staff , UMMC (University) (10 Jun 2003 - 11 Jun 2003)
  21. Psychiatric Morbidity among Drug Offenders In A Drug Rehabilitation Centre, 1st Lilly Postgraduate Conference, Kuala Lumpur, Malaysia. 15th- 16th September 2001, MPA/Lilly (National) (15 Sep 2001 - 16 Sep 2001)

ACADEMIC/PROFESSIONAL SERVICES

Evaluation
  1. (2022) External Assessor for Promotion to Professor (UKM) for Dr Chan Lai Fong, National, (External Assessor)
  2. (2022) Proposal Defence Ijazah Sarjana Sains. Calon Nursyaugina Sofree (S2130168/1), University, (External Assessor)
  3. (2022) Thesis Proposal by Dr Durgashina (Mgc 180012), University, (Internal Assessor)
  4. (2022) Thesis Proposal by Dr Jayatamarai (Mgc 180007), University, (Internal Assessor)
  5. (2022) Prevalence of Depression, Anxiety and Stress Among Medical University Lecturers in Malaysia During Covid-19 Pandemic, National, (Reviewer)
  6. (2022) 'Mental Health Status Based On Dass-21, Brief Resilience Scale and Satisfaction With Life Scale Among Corporate Staff in International Medical University'., National, (Reviewer)
  7. (2022) Pemeriksa Bagi Peperiksaan Klinikal Kes Pendek Sarjana Perubatan (Psikiatri) Bahagian I, National, (Internal Examiner)
  8. (2022) External Examiner, Faculty of Medicine and Health Sciences, Quest International University, National, (External Examiner)
  9. (2022) Clinical Professional Examination, Faculty of Medicine and Health Sciences, Quest International University, National, (External Examiner)
  10. (2022) Pemeriksa Bagi Peperiksaan Sarjana Perubatan (Psikiatri) Bahagian III (Viva Konsultansi), National, (Internal Examiner)
  11. (2022) 'Purging With Mirtazapine. a Clinical Experience.', National, (Reviewer)
  12. (2022) Phd Candidate Mohd Rashidi Mohamed Mha16005, University, (Internal Assessor)
  13. (2022) Mmedscience Research Proposol by Shereen Sayed Ali, University, (Internal Assessor)
  14. (2022) External Assessor for Promotion to Professor (UKM) for Dr Nik Ruzyanei, National, (External Assessor)
  15. (2022) Tardive Dyskinesia Advisory Board, International, (Reviewer)
  16. (2015) Regular peer reviewer for Malaysian Journal of Psychiatry, (Reviewer)
  17. (2009) Reviewer for Malaysian Jpurnal of Psychiatry, (Reviewer)
  18. Asia-Pacific Journal of Clinical Oncology (Title: Prevalence of distress in cancer patients undergoing chemotherapy)
Contribution to external organisation
  1. (2022) Medical Advisory Board Meeting: Understanding Today S Clinical Practice and Roles of Lurasidone in The Management of Schizophrenia & Bipolar I Depression in Malaysia, National, (Expert Advisor)
  2. (2022) South East Asia Tardive Dyskinesia Advisory Board Meeting, International, (Expert Advisor)
  3. (2016) Projek Kurikulum Nasional Sarjana Perubatan Klinikal, Projek Kurikulum Nasional Sarjana Perubatan Klinikal
Contribution to event
  1. (2022) Penceramah Bengkel Part 1 Revision Course, Master Perubatan Psikiatri, National, (Panelist/Moderator)

SUPERVISION

Under Graduate Students
  1. (2021) Stage 3.2 Stream H
  2. (2021) Psychiatry Posting Stage 3.2 Stream H
  3. (2007) Phase 3b Psychiatry Posting Research Project
  4. (2007) Phase 3a MBBS Elective Research Project - Prevalence of sexual dysfunction
  5. (2006) Phase 3b Psychiatry Posting Research Project
  6. (2006) Phase 3a MBBS Elective Research Project -Symptomatology of ADHD in PPUM
  7. (2005) Phase 3b Psychiatry Posting Research Project
  8. (2005) Phase 3a MBBS Elective Research Project -Diagnostic stability of brief psychotic disorder
Postgraduate Student
PhD/ Doctoral
  1. (2003) Characteristics of First Episode Psychosis-Thesis, Dr Koh Ong Hui
Master
  1. (2019) -, TEJVINDER SINGH
  2. (2018) Positive Emotions in Depresssion, Dr Fabian Sunil Dass
  3. (2017) ADHD in Methadone Users, Dr Sharon Kaur
  4. (2017) -, JOHAN ARIFF BIN JUHARI
  5. (2016) The Assocoation between Verbal Working Memory, Visual Spatial Memory and Executive functioning with Functional Outcomes in Schizophrenia, Dr Sashi Moorthi
  6. (2016) Cognitive Dysfunction in Psychiatric Patients: Comparison between Schizophrenia, Bipiolar and Healthy Subjects, Dr Sylvia Wong Tyng Yng
  7. (2016) Attitude Of Medical Students Towards Psychiatric Illness, Dr Tan Tze Yin
  8. (2012) Prevalence of Major Depressive Disorder among Palliative Care Patients, Dr Ng Su Huey
  9. (2011) The Prevalence and Associated risk Factors of Female Sexual Dysfunction Among Healthcare Personnel, Dr Gurdeep Singh
  10. (2011) Depressive and Anxiety Disorders and Their associations in Women with Polycystic Ovarian Syndrome, Dr Wah
  11. (2010) Sexual dysfunction in Gynaecological Patients, Dr Vasanthi Periasamy
  12. (2010) Anxiety Comorbidity in Schizophrenia, Dr Lee Wen Jih
  13. (2008) Depression in Epilepsy - Thesis, Dr Salina Mohamed (University of Malaya (UM))
  14. (2008) Depression and Breast Feeding - Thesis, Dr Anandjit Singh (University of Malaya (UM))
  15. (2004) Psychiatric Comorbidity in SLE - Thesis, Dr Khoo Yee Liam (University of Malaya (UM))

TEACHING

Master
  1. (2022) NA - Master Psychomed
  2. (2021) - - Master Psychomed
  3. (2020) MNGC6111 - Mngc6111
  4. (2020) MNGC6103 - Mngc6103
  5. (2020) MNGC6102 - Paper 2 (Saq)
  6. (2020) MNGC6101 - Paper 1 (Essay)
  7. (2019) MNGC6111 - Mngc6111
  8. (2019) MNGC6103 - Mngc6103
  9. (2019) MNGC6102 - Paper 2 (Saq)
  10. (2019) MNGC6101 - Paper 1 (Essay)
  11. (2014) Masters Psychological Medicine
  12. (2013) Masters Psychological Medicine
  13. (2013) Master in Psychological Medicine, Weekly Colloqium (Mpm)
  14. (2013) Master in Psychological Medicine, Daily Chart Rounds (Mpm)
  15. (2012) Masters Psychological Medicine Conjoint Exams Revision Course
  16. (2012) Master in Psychological Medicine, Daily Chart Rounds (Mpm)
  17. (2011) Masters Psychological Medicine General Psychiatry Lectures
  18. (2011) Masters Psychological Medicine Conjoint Exams Revision Course
  19. (2011) Master in Psychological Medicine,Weekly Postgraduate Case Conference (Mpm)
  20. (2011) Master in Psychological Medicine, Weekly Neuropsychiatric Case Conference (Mpm)
  21. (2011) Master in Psychological Medicine, Weekly Colloqium (Mpm)
  22. (2011) Master in Psychological Medicine, Daily Bedside Clinical Teaching (Mpm)
  23. (2011) Master in Psychological Medicine, Daily Chart Rounds (Mpm)
  24. (2010) Masters Psychological Medicine General Psychiatry Lectures
  25. (2010) Masters Psychological Medicine Conjoint Exams Revision Course
  26. (2010) Master in Psychological Medicine,Weekly Postgraduate Case Conference (Mpm)
  27. (2010) Master in Psychological Medicine, Weekly Neuropsychiatric Case Conference (Mpm)
  28. (2010) Master in Psychological Medicine, Weekly Colloqium (Mpm)
  29. (2010) Master in Psychological Medicine, Daily Bedside Clinical Teaching (Mpm)
  30. (2010) Master in Psychological Medicine, Daily Chart Rounds (Mpm)
  31. (2009) Master in Psychological Medicine, Weekly Neuropsychiatric Case Conference (Mpm)
  32. (2009) Master in Psychological Medicine,Weekly Postgraduate Case Conference (Mpm)
  33. (2009) Masters Psychological Medicine Conjoint Exams Revision Course
  34. (2009) Masters Psychological Medicine General Psychiatry Lectures
  35. (2009) Master in Psychological Medicine, Weekly Colloqium (Mpm)
  36. (2009) Master in Psychological Medicine, Daily Bedside Clinical Teaching (Mpm)
  37. (2008) Master in Psychological Medicine, Daily Bedside Clinical Teaching (Mpm)
  38. (2008) Master in Psychological Medicine, Daily Chart Rounds (Mpm)
  39. (2008) Master in Psychological Medicine, Weekly Colloqium (Mpm)
  40. (2008) Master in Psychological Medicine, Weekly Neuropsychiatric Case Conference (Mpm)
  41. (2008) Master in Psychological Medicine,Weekly Postgraduate Case Conference (Mpm)
  42. (2008) Masters Psychological Medicine Conjoint Exams Revision Course
  43. (2008) Masters Psychological Medicine General Psychiatry Lectures
  44. (2007) MPM - Master in Psychological Medicine, Weekly Neuropsychiatric Case Conference
  45. (2007) MPM - Master in Psychological Medicine, Weekly Colloqium
  46. (2007) MPM - Master in Psychological Medicine, Psychiatry Interview Techniques
  47. (2007) MPM - Master in Psychological Medicine, Forensic Posting (Hospital Bahagia Ulu Kinta)
  48. (2007) MPM - Master in Psychological Medicine, Daily Chart Rounds
  49. (2007) MPM - Master in Psychological Medicine, Daily Bedside Clinical Teaching
  50. (2007) MPM - Master in Psychological Medicine,Weekly Postgraduate Case Conference
  51. (2007) Master in Psychological Medicine, Psychosexual Disorders (Mpm)
  52. (2007) Master in Psychological Medicine (Mpm) Psychiatry Interview Techniques
  53. (2006) Master in Psychological Medicine (Mpm) Psychiatry Interview Techniques
  54. (2006) Master in Psychological Medicine, Forensic Posting (Hospital Bahagia Ulu Kinta) (Mpm)
  55. (2006) Master in Psychological Medicine,Weekly Postgraduate Case Conference (Mpm)
  56. (2006) Master in Psychological Medicine, Weekly Neuropsychiatric Case Conference (Mpm)
  57. (2006) Master in Psychological Medicine, Weekly Colloqium (Mpm)
  58. (2006) Master in Psychological Medicine, Psychosexual Disorders (Mpm)
  59. (2006) Master in Psychological Medicine, Psychiatry Interview Techniques (Mpm)
  60. (2006) Master in Psychological Medicine, Daily Chart Rounds (Mpm)
  61. (2006) Master in Psychological Medicine, Daily Bedside Clinical Teaching (Mpm)
  62. (2005) Master in Psychological Medicine (Mpm) Psychiatry Interview Techniques
  63. (2005) Master in Psychological Medicine, Daily Chart Rounds (Mpm)
  64. (2005) Master in Psychological Medicine, Daily Bedside Clinical Teaching (Mpm)
  65. (2005) Master in Psychological Medicine, Psychosexual Disorders (Mpm)
  66. (2005) Master in Psychological Medicine, Weekly Colloqium (Mpm)
  67. (2005) Master in Psychological Medicine, Weekly Neuropsychiatric Case Conference (Mpm)
  68. (2005) Master in Psychological Medicine,Weekly Postgraduate Case Conference (Mpm)
  69. (2005) Master in Psychological Medicine, Forensic Posting (Hospital Bahagia Ulu Kinta) (Mpm)
Bachelor
  1. (2022) UMMP - Examiner of Eop Stage 3.3
  2. (2021) UMMP - Examiner of Eop Stage 3.3
  3. (2021) Tutorials Posting F Stream 4
  4. (2021) Schizophrenia
  5. (2021) Tutorials for Posting E Stream 3
  6. (2021) Tutorials for Posting G Steam 1
  7. (2021) Tutorials for Posting H Stream 2
  8. (2021) UMMP - Universiti Malaya Medical Programme
  9. (2017) MBBS - Tutorials
  10. (2017) MBBS - Lectures
  11. (2016) MBBS - Lectures
  12. (2016) MBBS - Tutorials
  13. (2015) MBBS - Tutorials
  14. (2015) MBBS - Lectures
  15. (2014) Tutorials
  16. (2014) CFCS - Community Family Case Studies
  17. (2013) CFCS - Community Family Case Studies
  18. (2013) Psychological Medicine Posting
  19. (2013) Mbbs
  20. (2013) District Posting, General Psychiatry (Banting District Hospital)
  21. (2012) CFCS - Community Family Case Studies
  22. (2012) Psychological Medicine Posting
  23. (2012) District Posting, General Psychiatry (Banting District Hospital)
  24. (2011) CFCS - Community Family Case Studies
  25. (2011) GMEW1002 - Sexual Health
  26. (2011) Psychological Medicine Posting-Clinics
  27. (2011) Psychological Medicine Posting
  28. (2011) Psychological Medicine Posting
  29. (2011) Phase 2 Lectures
  30. (2011) General Psychiatry (Bukit Kuda Klang)
  31. (2011) District Posting, General Psychiatry (Banting District Hospital)
  32. (2011) PBL - Problem Based Learning
  33. (2010) Psychological Medicine Posting-Clinics
  34. (2010) PBL - Problem Based Learning
  35. (2010) District Posting, General Psychiatry (Banting District Hospital)
  36. (2010) General Psychiatry (Bukit Kuda Klang)
  37. (2010) Phase 2 Lectures
  38. (2010) Psychological Medicine Posting
  39. (2010) Psychological Medicine Posting
  40. (2010) GMEW1002 - Sexual Health
  41. (2010) CFCS - Community Family Case Studies
  42. (2009) Psychological Medicine Posting
  43. (2009) PBL - Problem Based Learning
  44. (2009) GMEW1002 - Kesihatan Seksual
  45. (2009) CFCS - Community Family Case Studies
  46. (2009) Phase 2 Lectures
  47. (2009) District Posting, General Psychiatry (Banting District Hospital)
  48. (2009) Psychological Medicine Posting-Clinics
  49. (2009) General Psychiatry (Bukit Kuda Klang)
  50. (2009) Psychological Medicine Posting
  51. (2008) General Psychiatry (Bukit Kuda Klang)
  52. (2008) CFCS - Community Family Case Studies
  53. (2008) Psychological Medicine Posting
  54. (2008) District Posting, General Psychiatry (Banting District Hospital)
  55. (2008) Psychological Medicine Posting-Clinics
  56. (2008) GMEW1002 - Sexual Health
  57. (2008) Phase 2 Lectures
  58. (2008) Psychological Medicine Posting
  59. (2007) PBL - Problem Based Learning
  60. (2007) Psychological Medicine Posting
  61. (2007) CFCS - Community Family Case Studies
  62. (2007) Psychological Medicine Posting
  63. (2007) District Posting, General Psychiatry (Banting District Hospital)
  64. (2007) General Psychiatry (Bukit Kuda Klang)
  65. (2007) Phase 2 Lectures
  66. (2007) Problem Based Learning (Pbl)
  67. (2007) Psychological Medicine Posting-Clinics
  68. (2006) District Posting, General Psychiatry (Banting District Hospital)
  69. (2006) GMEW1002 - Kesihatan Seksual
  70. (2006) Community Family Case Studies (Cfcs )
  71. (2006) General Psychiatry (Bukit Kuda Klang)
  72. (2006) Phase 2 Lectures
  73. (2006) Psychological Medicine Posting
  74. (2006) Psychological Medicine Posting
  75. (2005) GMEW1002 - Sexual Health
  76. (2005) Psychological Medicine Posting-Clinics
  77. (2005) Psychological Medicine Posting
  78. (2005) Psychological Medicine Posting
  79. (2005) Problem Based Learning (Pbl)
  80. (2005) Phase 2 Lectures
  81. (2005) General Psychiatry (Bukit Kuda Klang)
  82. (2005) District Posting, General Psychiatry (Banting District Hospital)
  83. (2005) Community Family Case Studies (Cfcs )

PATENT/IPR

  • Schizophrenia Family Education Kit
    Educational CDS (National)

SOCIAL RESPONSIBILITY ACTIVITIES

  • World Psychiatric Association Section On Urban Mental Health Committee Member, (01 Jan 2015 - 31 Dec 2017)
  • Urusetia Kursus Bimbangan Untuk Bakal Calon Program Sarjana Psikiatri Kementerian Kesihatan, (26 Nov 2012)
  • Organising Committee for The 5th Beta: Bipolar Educational Training for Asia Forum, Kuala Lumpur, (06 Jul 2012 - 07 Jul 2012)
  • Penceramah Jemputan. Jabatan Psikiatri Hospital Kuala Pilah Bengkel Psikiatri, (16 Jan 2012)
  • Updates On Mood Disorders. Hospital Kuala Pilah Workshop On Psychiatric Updates for Paramedical Staff . 26th Sept 2011, (26 Sep 2011 - 05 Sep 2011)
  • Ahli Jawatankuasa Rukun Tetangga, (01 Jun 2010)
  • Organising Committee for International Society of Bipolar Disorders (Malaysian Chapter) Congress. Putrajaya, 13th 14th March 2010, (13 Mar 2010 - 14 Mar 2010)
  • Penceramah Infopsikik (Musim Ke-Dua). Tv2. Mac 2009, (03 Mar 2009 - 03 Mar 2009)
  • Organising Committee for Cinp Pacific-Asia Regional Meeting. 2 5 March 2008. Kuala Lumpur Convention Centre, (02 Mar 2008 - 05 Mar 2008)
  • Organising Committee (Secretary)for 13th Malaysian Conference On Psychological Medicine; 7th 9th June 2007, (07 Jun 2007 - 09 Jun 2007)
  • Speaker At Bahagian Perkhidmatan Farmasi, Jab Kesihatan Pahang, Mental Health Seminar for Pharmacists Management of Bipolar Disorder, Kuantan 20th September 2006., (20 Sep 2006)
  • Penceramah Jemputan - Updates in Medical Rehabilitation for Caregivers Depression in Stroke Patients . University of Malaya, Kuala Lumpur. 6th September 2006, (06 Sep 2006)
  • Speaker At Schizophrenia Awareness Day :Violence in Schizophrenia and Relapse Prevention Malaysian Mental Health Foundation- Putra Hotel, Kuala Lumpur, 14th August 2006., (14 Aug 2006 - 14 Aug 2006)
  • Penceramah Jemputan - Persatuan Mencegah Dadah Malaysia (Pemadam)- Kolokium:Memperkasa Institusi Keluarga Pusat Komuniti Sri Petaling. 11 September 2004, (11 Sep 2004)
  • Malaysian Pharmaceutical Society Seminar On Management of Mental Disorders Early Intervention in Psychosis and Psychosocial Approach to Managing Mental Disorders Royal Adelphi Hotel, Seremban. 24th August 2004, (24 Aug 2004)
  • Penceramah Jemputan - Persekutuan Orang Pekak Malaysia Persidangan Keluarga Bekak Bahagia Trauma Ibubapa Apabila Mendapat Anak Pekak. Hotel Crown Princess, Kl. 8th August 2004., (08 Aug 2004)
  • Penceramah Jemputan - Bengkel Pelan Tindakan Kesihatan Mental Negeri Kelantan Pengesanan Awal Masalah Kesihatan Mental Tumpat, Kelantan. 6th 8th April 2004, (06 Apr 2004)
  • Sukarelawan / Elektif - Pusat Serenti Rawang, December 2001, (01 Dec 2001 - 31 Dec 2001)